Genetic risk score in patients with the APOE2/E2 genotype as a predictor of familial dysbetalipoproteinemia

Journal of clinical lipidology(2023)

引用 0|浏览5
暂无评分
摘要
•5 % of APOE2/E2 homozygotes develop familial dysbetalipoproteinemia (FD).•several gene SNPs are individual additive factors influencing FD development.•unweighted GRS2 is a clinically relevant tool that improves the prediction of FD.
更多
查看译文
关键词
Familial dysbetalipoproteinemia,Cardiovascular risk,Polymorphism,Genetic risk score
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要